Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_000261.2(MYOC):c.600A>G (p.Arg200=)

CA421773580

876999 (ClinVar)

Gene: MYOC

Condition: primary open angle glaucoma

Inheritance Mode: Autosomal dominant inheritance

Link to MONDO

UUID: 35a7aafa-4fec-436f-9c2b-709e37e4895a

HGVS expressions

NM_000261.2:c.600A>G

NM_000261.2(MYOC):c.600A>G (p.Arg200=)

NC_000001.11:g.171652012T>C

CM000663.2:g.171652012T>C

NC_000001.10:g.171621152T>C

CM000663.1:g.171621152T>C

NC_000001.9:g.169887775T>C

NG_008859.1:g.5622A>G

ENST00000037502.11:c.600A>G

ENST00000638471.1:c.130+470A>G

ENST00000037502.10:c.600A>G

ENST00000614688.1:c.600A>G

NM_000261.1:c.600A>G

Uncertain Significance

PM2_Supporting

BA1 BS3 BS1 BP7 BP4 PS4 PS2 PS1 PS3 PP1 PP3 PM5 PM4 PM6

Evidence Links 0

Expert Panel

Glaucoma VCEP

Criteria Specification Information

Criteria Specification: ClinGen Glaucoma Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1.1

Criteria Specification Approval History

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Glaucoma VCEP

The c.600A>G variant in MYOC is a synonymous variant (p.Arg200=). This variant was not found in any population of gnomAD (v2.1.1), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles. Although this synonymous variant was not predicted to affect splicing, as assessed with SpliceAI (≤ 0.2), it had a CADD score (v1.6) = 12.60, which did not meet the ≤ 10 threshold for BP4 and a GERP score = 5.07 (threshold <0), not meeting BP7 and indicating conservation at this site. There was no functional evidence predicting a damaging or benign impact of this variant on MYOC function. This variant was identified in laboratory based testing, but has not yet been found in a proband with juvenile or primary open angle glaucoma, thus PS4 did not apply. In summary, this variant met the criteria to receive a score of 1 and to be classified as a variant of uncertain significance (uncertain significance classification range -1 to 5) for primary open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): PM2_Supporting

PM2_Supporting

This variant was not found in any population of gnomAD (v2.1.1), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles.

BA1

This criterion was not met as PM2_Supporting has been met.

BS3

No functional evidence has been found for this variant.

BS1

This criterion was not met as PM2_Supporting has been met.

BP7

Although this synonymous variant was not predicted to affect splicing, as assessed with SpliceAI (≤ 0.2), it had a GERP score = 5.07 (threshold <0), indicating conservation at this site.

BP4

Although this synonymous variant was not predicted to affect splicing, as assessed with SpliceAI (≤ 0.2), it had a CADD score (v1.6) = 12.60, which does not meet the ≤ 10 threshold for BP4.

PS4

This variant was identified in laboratory based testing, but has not yet been found in a proband with juvenile or primary open angle glaucoma.

PS2

This variant has not been identified de novo.

PS1

This variant does not involve an amino acid change.

PS3

No functional evidence has been found for this variant.

PP1

No segregations have been reported for this variant.

PP3

This is not a missense variant.

PM5

This is not a missense variant.

PM4

This variant does not cause a protein length change.

PM6

This variant has not been identified de novo.

Approved on: 2023-08-08

Published on: 2023-08-08

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.